Patent details
EP3564244 Title: CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO [1',2':4,5]PYRAZINO [2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE
Basic Information
- Publication number:
- EP3564244
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP191676261
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO [1',2':4,5]PYRAZINO [2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE
- French Title of Invention:
- FORMES CRISTALLINES DU (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-MÉTHANOPYRIDO [1',2':4,5]PYRAZINO [2,1-B][1,3]OXAZÉPINE-10-CARBOXAMIDE
- German Title of Invention:
- KRISTALLINE FORMEN VON (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUORBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZEPIN-10-CARBOXAMID
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 06/10/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 17/10/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 13/09/2023
- Unitary Effect Registration Date:
- 17/10/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 19/06/2015
- Grant date:
- 13/09/2023
- EP Publication Date:
- 06/11/2019
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/09/2023
- EP B1 Publication Date:
- 13/09/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/06/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/09/2023
- Name:
- Gilead Sciences, Inc.
- Address:
- 333 Lakeside Drive, Foster City, CA 94404, United States (US)
Inventor
1
- Name:
- ZIA, Vahid
- Address:
- United States (US)
2
- Name:
- CHEN, Irene
- Address:
- United States (US)
3
- Name:
- KEATON, Katie Ann
- Address:
- United States (US)
4
- Name:
- CARRA, Ernest A.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201462015238 P
- Priority Date:
- 20/06/2014
- Priority Country:
- United States (US)
2
- Priority Number:
- 201462017183 P
- Priority Date:
- 25/06/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07D 498/14; A61K 31/537; A61P 31/18;
Publication
European Patent Bulletin
1
- Issue number:
- 202337
- Publication date:
- 13/09/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202341
- Publication date:
- 11/10/2023
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202346
- Publication date:
- 15/11/2023
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202346
- Publication date:
- 15/11/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|